Mahama Pledges Transparency in Opioid Import Investigation
President John Dramani Mahama has vowed to ensure full accountability for individuals and companies implicated in the importation of alleged opioids into Ghana and other West African countries.
During his first State of the Nation Address (SONA) of his second term on Thursday, February 27, 2025, Mahama assured the public that details of the ongoing investigation would be transparently shared.
“We await thorough and unbiased investigation into the alleged opioid pill importation into Ghana and other West African countries. The outcome will be shared, and I can assure you, necessary action will be taken,” President Mahama stated.
FDA Suspends Indian Drug Manufacturer’s Certification
On February 26, 2025, the Food and Drugs Authority (FDA) suspended the Good Manufacturing Practices (GMP) certification of Aveo Pharmaceuticals, an Indian drug manufacturer, after reports linked it to the illegal distribution of opioid-based medications in West Africa.
This follows a BBC Africa Eye investigation, which revealed that Aveo Pharmaceuticals, through Westfin International, allegedly exported unapproved drugs containing tapentadol and carisoprodol to Ghana, Nigeria, and Côte d’Ivoire.
These substances, classified as highly addictive opioids, pose serious health risks, including respiratory failure and death when abused.
In response to the exposé, the FDA has directed Samos Pharma, a Ghana-based importer, to cease all business dealings with Aveo Pharmaceuticals and Westfin International.
Additionally, the registration process for six pharmaceutical products from Masters Pharmaceutical Limited—which had planned to use Aveo Pharmaceuticals as a contract manufacturer—has been put on hold.
Government’s Commitment to Justice
President Mahama’s administration has emphasized its commitment to ensuring justice in this case. The government is closely monitoring the ongoing investigations and has promised to take decisive action against any individuals or companies found guilty of illegal drug distribution.
The President reiterated that public health and safety remain a top priority for his government and urged all regulatory agencies to strengthen oversight in Ghana’s pharmaceutical industry.
Source: CNR